Quality Assurance in Quantitative Molecular Assays

Quality assurance in quantitative molecular assays is the system of standards, controls, and reporting practices that make expression measurements accurate, reproducible, and comparable across runs and laboratories. Without it, a numerical result from qPCR, RNA-seq, or a multigene assay cannot be trusted or compared.

Definition

Quality assurance in quantitative molecular assays is the coordinated use of standardised procedures, controls, reference materials, and transparent reporting to ensure that measurements of gene or protein expression are analytically valid and reproducible.

Scope

This topic covers the pre-analytical, analytical, and post-analytical sources of variation in quantitative assays, the role of reference materials and spike-in controls, the function of reporting standards such as MIQE, and the consortium benchmarking studies that established platform reproducibility. It is framed as a methodological and standards topic, not as a laboratory operating procedure or accreditation manual.

Core questions

• What are the pre-analytical, analytical, and post-analytical sources of error?
• How do reference materials and controls anchor a quantitative measurement?
• Why does transparent reporting matter for reproducibility?
• How is the reproducibility of a measurement platform demonstrated?

Key concepts

• Pre-analytical, analytical, and post-analytical phases
• Reference materials and calibrators
• Spike-in and process controls
• Reporting standards (e.g. MIQE)
• Inter-laboratory reproducibility
• Analytical validity

Mechanisms

Variation enters a quantitative assay at every stage: sample collection and RNA integrity (pre-analytical), amplification efficiency, sequencing depth, antibody performance and run-to-run drift (analytical), and normalisation, thresholding, and interpretation (post-analytical). Quality assurance counters these by fixing procedures, including positive, negative, and process controls, and anchoring measurements to reference materials and spike-in standards so that signal can be calibrated. Transparent reporting of these elements, as required by the MIQE and digital MIQE guidelines (Bustin et al., 2009; Huggett et al., 2013), lets others judge and reproduce a result. Large multi-laboratory studies demonstrate the achievable reproducibility of microarray and RNA-seq platforms and define the practices that support it (MAQC Consortium, 2006; SEQC/MAQC-III Consortium, 2014).

Clinical relevance

Reliable quality assurance is what allows molecular measurements to be used in diagnostic and prognostic reporting, and recognising its components helps in appraising the trustworthiness of a result. This entry describes quality principles and standards at a methodological level and does not constitute a clinical laboratory protocol, accreditation requirement, or basis for patient management.

Evidence & guidelines

Reporting standards for quantitative PCR and digital PCR are defined by the MIQE and digital MIQE guidelines (Bustin et al., 2009; Huggett et al., 2013). Reproducibility of expression platforms is documented by the MicroArray Quality Control project (MAQC Consortium, 2006) and the Sequencing Quality Control study for RNA-seq (SEQC/MAQC-III Consortium, 2014).

History

As quantitative molecular assays spread in the 2000s, concern about irreproducible results prompted coordinated standardisation. The MAQC project (2006) tested microarray reproducibility across laboratories, the MIQE guidelines (2009) standardised qPCR reporting, and later efforts extended this to digital PCR (2013) and RNA-seq (2014), establishing quality assurance as a discipline within quantitative expression analysis.

Debates

How comparable are measurements across platforms and laboratories?

Even with controls, absolute values can differ between platforms and sites, so emphasis is placed on relative comparisons, shared reference materials, and transparent reporting; how far cross-platform results can be harmonised remains an open methodological question.

Key figures

• Stephen Bustin
• Jim Huggett
• Leming Shi

Seminal works

• bustin-2009
• maqc-2006
• seqc-2014

Frequently asked questions

What is the difference between a reference material and a control in a molecular assay?

A reference material is a characterised standard used to calibrate or anchor a measurement, while a control is a sample run alongside test samples to confirm the assay is working as expected; both contribute to quality assurance but serve different roles.

Why are reporting standards like MIQE important?

Standards specify the experimental details that must be disclosed so that a quantitative result can be evaluated and reproduced by others; without them, differences between studies may reflect undocumented technical variation rather than biology.